Inovio Pharmaceuticals
INO
#9595
Rank
โ‚น12.29 B
Marketcap
โ‚น118.94
Share price
7.83%
Change (1 day)
-40.66%
Change (1 year)

Revenue for Inovio Pharmaceuticals (INO)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of โ‚น5.86 Million a decrease over the revenue in the year 2024 that were of โ‚น18.68 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Inovio Pharmaceuticals from 1999 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A-100%
2025 โ‚น5.86 M-68.6%
2024 โ‚น18.68 M-73.03%
2023 โ‚น69.26 M-91.84%
2022 โ‚น0.84 B542.86%
2021 โ‚น0.13 B-75.63%
2020 โ‚น0.54 B84.84%
2019 โ‚น0.29 B-86.24%
2018 โ‚น2.13 B-20.94%
2017 โ‚น2.69 B12.16%
2016 โ‚น2.40 B-10.86%
2015 โ‚น2.69 B306.84%
2014 โ‚น0.66 B-20.35%
2013 โ‚น0.83 B268.95%
2012 โ‚น0.22 B-56.48%
2011 โ‚น0.51 B88.19%
2010 โ‚น0.27 B-34.93%
2009 โ‚น0.42 B319.72%
2008 โ‚น0.10 B-46.56%
2007 โ‚น0.18 B22.83%
2006 โ‚น0.15 B-37.57%
2005 โ‚น0.24 B386.75%
2004 โ‚น50.54 M1278.56%
2003 โ‚น3.66 M-59.66%
2002 โ‚น9.08 M
2000 โ‚น0.25 B-32.09%
1999 โ‚น0.38 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น9.243 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.426 TN/A๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น6.073 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น2.852 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น6.308 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น4.236 TN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
โ‚น60.6 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚น59.66 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA